Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > A question Pancreatic Cancer and Theralase
View:
Post by steamfitter on May 28, 2021 7:25pm

A question Pancreatic Cancer and Theralase

Could the same Theralase procedure be used for Pancreatic cancer

New Pancreatic Cancer Treatment Penetrates Tough Tumors | Freethink
Comment by ScienceFirst on May 28, 2021 8:41pm
No.  They don't have this indication on their list.  Dr. McFarland designs PDCs specific for certain type of indications.  Tailored for each of them or a category of them.  It's all case by case.    For example, TLD-1433 is not efficient against melanoma.  By chance, our Ru(II) TLD-1433 (alone or with transferrin) has been confirmed for 6 indications ...more  
Theralase Technologies Inc.